- Home
- RDCM vs STXS Comparison
RDCM vs STXS Comparison
Compare RDCM & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDCM | STXS |
|---|---|---|
| Founded | 1985 | 1990 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.7M | 210.0M |
| IPO Year | 1997 | 2004 |
Fundamental Metrics
Financial Performance| Metric | RDCM | STXS |
|---|---|---|
| Price | $12.58 | $2.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $18.00 | $4.00 |
| AVG Volume (30 Days) | 97.2K | ★ 516.1K |
| Earning Date | 02-11-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.57 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $68,901,000.00 | $30,075,000.00 |
| Revenue This Year | $18.86 | $24.21 |
| Revenue Next Year | $11.39 | $29.83 |
| P/E Ratio | $19.52 | ★ N/A |
| Revenue Growth | 17.27 | ★ 19.62 |
| 52 Week Low | $9.88 | $1.54 |
| 52 Week High | $15.98 | $3.59 |
Technical Indicators
Market Signals| Indicator | RDCM | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 30.13 |
| Support Level | $11.68 | $1.98 |
| Resistance Level | $12.88 | $2.82 |
| Average True Range (ATR) | 0.47 | 0.12 |
| MACD | -0.05 | -0.07 |
| Stochastic Oscillator | 31.91 | 5.95 |
Price Performance
Historical ComparisonAbout RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.